The FDA sent an early safety alert warning clinicians of deployment failures with certain Boston Scientific AXIOS Stent and ...

Boston Scientific Corp. looked ready to keep steamrolling down the acquisition path, carrying the momentum from last year, with the news that it is acquiring Penumbra Inc., a company that makes ...

Boston Scientific is purchasing heart-device company Penumbra for roughly $14.5 billion in cash and stock, marking the largest deal in two decades for the medtech company with a large Minnesota ...

Boston Scientific agreed to buy medtech firm Penumbra in a $14.5 billion deal on Thursday, its second‑largest takeover ever, ...

Boston Scientific is capping off a busy week with a major buyout, entering a deal worth about $14.5 billion to acquire ...

NBM provides practical and scalable options for copier leasing in Boston, giving local businesses access to modern office equipment without high upfront costs. These programs allow companies to align ...

As pharmaceutical development becomes increasingly global and highly regulated, pharmacovigilance translation has moved from a supporting function to a central pillar of drug safety operations.

Boston Scientific is recommended as a buy with a $109 target price, implying 14% upside, driven by robust demand and niche leadership. BSX outpaces market growth through focused M&A, strong execution ...

OTTAWA, Ontario (AP) — Brianne Jenner scored in the eighth round of the shootout as the Ottawa Charge defeated the Boston Fleet 3-2 on Saturday in the Professional Women’s Hockey League. Gwyneth ...

Boston Scientific continues to deliver robust growth, but valuation limits upside despite strong execution and leading positions in key medical device markets. BSX's growth drivers—Farapulse (PFA), ...

Angelo De Rosa (left) will succeed the retiring Scott Olson (right) as president of the Boston Scientific CRMDx business. [Images from LinkedIn] Boston Scientific (NYSE: BSX) + will have a transition ...